Economic evaluation of a randomized clinical trial of haemodilution with cell salvage in aortic surgery.
BACKGROUND
This study evaluated the costs of acute normovolaemic haemodilution (ANH) and intraoperative cell salvage (ICS) versus homologous blood transfusion in aortic surgery in a prospective multicentre randomized trial.


METHODS
One hundred and forty-five patients were randomized either to standard transfusion practice (homologous) or to a combination of ANH and ICS (autologous). Costs for each inpatient admission were identified. Cell salvage costs were assigned on the assumption that 50 operations were done each year employing a trained cell salvage operator. The results were analysed statistically using bias-corrected bootstrap analysis.


RESULTS
Patients who had transfusion of homologous blood received some 251 units and those having a homologous transfusion received 103 units (P = 0.008). There was no difference in morbidity, mortality and duration of hospital stay. Transfusion-related mean costs were similar at 340 UK pounds for patients having a homologous transfusion and 357 UK pounds for those receiving autologous blood (mean difference 17 UK pounds (95 per cent confidence interval [c.i.]--184 UK pounds to 174 UK pounds); P not significant). There was also no significant difference in mean overall costs: 5859 UK pounds for homologous and 5384 UK pounds for autologous transfusion (mean difference--475 UK pounds (95 per cent c.i.--2231 UK pounds to 1342 UK pounds)). Sensitivity analysis showed that costs remained similar for 20 and 150 operations per annum. Exclusion of a dedicated cell salvage operator reduced autologous transfusion costs but did not have a significant impact on overall cost.


CONCLUSIONS
Autologous transfusion is cost neutral in aortic surgery even when surgical activity is low.
Haynes
S L
SL
Academic Surgery Unit, South Manchester University Hospital, Wythenshawe, Manchester, M23 9LT, UK. S_Haynes@fs1.with.man.ac.uk
Torella
F
F
Wong
J C L
JC
Dalrymple
K
K
James
M
M
McCollum
C N
CN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001014:Aortic Aneurysm / Q000601:surgery*; D001804:Blood Transfusion, Autologous; D003362:Cost-Benefit Analysis; D006438:Hemodilution / Q000191:economics* / Q000379:methods; D006801:Humans; D007430:Intraoperative Care / Q000191:economics* / Q000379:methods; D007902:Length of Stay; D008875:Middle Aged; D011446:Prospective Studies; D016879:Salvage Therapy / Q000191:economics / Q000379:methods; D012680:Sensitivity and Specificity